美国胸科医师学会最新肺结节诊疗指南解读
摘要
<正>近年来低剂量螺旋CT在我国健康体检中逐渐普及,肺部结节病灶检出率明显增高,而这些结节病灶良恶性判断及处理方法经常成为困扰临床医师及影像科医师的难题。2013年美国胸科医师学会(American College of Chest Physicians,ACCP)发布了第3版单发或多发肺结节(pulmonary nodule)
引文
[1]Gould MK,Donington J,Lynch WR,et al.Evaluation of individuals with pulmonary nodules:when is it lung cancer?Diagnosis and management of lung cancer,3rd ed[J].Chest,2013,143(5 Suppl):E93S-E120S.
[2]Ost D,Fein AM,Feinsilver SH.The solitary pulmonary nodule[J].N Engl J Med,2003,348(25):2535-2542.
[3]Ost DE,Gould MK.Decision making in patients with pulmonary nodules[J].Am J Respir Crit Care Med,2012,185(4):363-372.
[4]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺部结节诊治中国专家共识[J].中华结核和呼吸杂志,2015,38(4):249-254.
[5]Ost D,Fein A.Management strategies for the solitary pulmonary nodule[J].Curr Opin Pulm Med,2004,10(4):272-278.
[6]Gould MK,Ananth L,Barnett PG.A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J].Chest,2007,131(2):383-388.
[7]Swensen SJ,Silverstein MD,Ilstrup DM,et al.The probability of malignancy in solitary pulmonary nodules.Application to small radiologically indeterminate nodules[J].Arch Intern Med,1997,157(8):849-855.
[8]Herder GJ,van Tinteren H,Golding RP,et al.Clinical prediction model to characterize pulmonary nodules:validation and added value of 18F-fluorodeoxyglucose positron emission tomography[J].Chest,2005,128(4):2490-2496.
[9]Cronin P,Dwamena BA,Kelly AM,et al.Solitary pulmonary nodules:meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy[J].Radiology,2008,246(3):772-782.
[10]Almeida FA,Uzbeck M,Ost D.Initial evaluation of the non small cell lung cancer patient:diagnosis and staging[J].Curr Opin Pulm Med,2010,16(4):307-314.
[11]Wiener RS,Gould MK,Woloshin S,et al.What do you mean,a spot?a qualitative analysis of patients reactions to discussions with their physicians about pulmonary nodules[J].Chest,2013,143(3):672-677.
[12]Geddes DM.The natural history of lung cancer:a review based on rates of tumour growth[J].Br J Dis Chest,1979,73(1):1-17.
[13]Weiss W.Tumor doubling time and survival of men with bronchogenic carcinoma[J].Chest,1974,65(1):3-8.
[14]Steinfort DP,Khor YH,Manser RL,et al.Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer:systematic review and meta-analysis[J].Eur Respir J,2011,37(4):902-910.
[15]Eberhardt R,Anantham D,Ernst A,et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial[J].Am J Respir Crit Care Med,2007,176(1):36-41.
[16]Schwarz Y,Greif J,Becker HD,et al.Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images:the first human study[J].Chest,2006,129(4):988-994.
[17]Freixinet JL,Varela G,Molins L,et al.Benchmarking in thoracic surgery[J].Eur J Cardiothorac Surg,2011,40(1):124-129.
[18]Kates M,Swanson S,Wisnivesky JP.Survival following lobectomy and limited resection for the treatment of stageⅠnon-small cell lung cancer≤1 cm in size:a review of SEER data[J].Chest,2011,139(3):491-496.
[19]Baldwin DR,Eaton T,Kolbe J,et al.Management of solitary pulmonary nodules:how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?[J].Thorax,2002,57(9):817-822.
[20]Revel MP,Merlin A,Peyrard S,et al.Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules[J].AJR Am J Roentgenol,2006,187(1):135-142.
[21]Slattery MM,Foley C,Kenny D,et al.Long-term followup of non-calcified pulmonary nodules(<10 mm)identified during low-dose CT screening for lung cancer[J].Eur Radiol,2012,22(9):1923-1928.
[22]Mc Nulty W,Cox G,Au-Yong I.Investigating the solitary pulmonary nodule[J].BMJ,2012,344:E2759.
[23]Kim HY,Shim YM,Lee KS,et al.Persistent pulmonary nodular ground-glass opacity at thin-section CT:histopathologic comparisons[J].Radiology,2007,245(1):267-275.
[24]Kodama K,Higashiyama M,Takami K,et al.Treatment strategy for patients with small peripheral lung lesion(s):intermediate-term results of prospective study[J].Eur J Cardiothorac Surg,2008,34(5):1068-1074.
[25]Mun M,Kohno T.Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter[J].J Thorac Cardiovasc Surg,2007,134(4):877-882.
[26]Carretta A,Ciriaco P,Melloni G,et al.Surgical treatment of multiple primary adenocarcinomas of the lung[J].Thorac Cardiovasc Surg,2009,57(1):30-34.
[27]Ikeda K,Awai K,Mori T,et al.Differential diagnosis of ground-glass opacity nodules:CT number analysis by three-dimensional computerized quantification[J].Chest,2007,132(3):984-990.
[28]Kim TJ,Goo JM,Lee KW,et al.Clinical,pathological and thin-section CT features of persistent multiple ground-glass opacity nodules:comparison with solitary ground-glass opacity nodule[J].Lung Cancer,2009,64(2):171-178.
[29]Ng YL,Patsios D,Roberts H,et al.CT-guided percutaneous fine-needle aspiration biopsy of pulmonary nodules measuring 10 mm or less[J].Clin Radiol,2008,63(3):272-277.
[2]Ost D,Fein AM,Feinsilver SH.The solitary pulmonary nodule[J].N Engl J Med,2003,348(25):2535-2542.
[3]Ost DE,Gould MK.Decision making in patients with pulmonary nodules[J].Am J Respir Crit Care Med,2012,185(4):363-372.
[4]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺部结节诊治中国专家共识[J].中华结核和呼吸杂志,2015,38(4):249-254.
[5]Ost D,Fein A.Management strategies for the solitary pulmonary nodule[J].Curr Opin Pulm Med,2004,10(4):272-278.
[6]Gould MK,Ananth L,Barnett PG.A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J].Chest,2007,131(2):383-388.
[7]Swensen SJ,Silverstein MD,Ilstrup DM,et al.The probability of malignancy in solitary pulmonary nodules.Application to small radiologically indeterminate nodules[J].Arch Intern Med,1997,157(8):849-855.
[8]Herder GJ,van Tinteren H,Golding RP,et al.Clinical prediction model to characterize pulmonary nodules:validation and added value of 18F-fluorodeoxyglucose positron emission tomography[J].Chest,2005,128(4):2490-2496.
[9]Cronin P,Dwamena BA,Kelly AM,et al.Solitary pulmonary nodules:meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy[J].Radiology,2008,246(3):772-782.
[10]Almeida FA,Uzbeck M,Ost D.Initial evaluation of the non small cell lung cancer patient:diagnosis and staging[J].Curr Opin Pulm Med,2010,16(4):307-314.
[11]Wiener RS,Gould MK,Woloshin S,et al.What do you mean,a spot?a qualitative analysis of patients reactions to discussions with their physicians about pulmonary nodules[J].Chest,2013,143(3):672-677.
[12]Geddes DM.The natural history of lung cancer:a review based on rates of tumour growth[J].Br J Dis Chest,1979,73(1):1-17.
[13]Weiss W.Tumor doubling time and survival of men with bronchogenic carcinoma[J].Chest,1974,65(1):3-8.
[14]Steinfort DP,Khor YH,Manser RL,et al.Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer:systematic review and meta-analysis[J].Eur Respir J,2011,37(4):902-910.
[15]Eberhardt R,Anantham D,Ernst A,et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial[J].Am J Respir Crit Care Med,2007,176(1):36-41.
[16]Schwarz Y,Greif J,Becker HD,et al.Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images:the first human study[J].Chest,2006,129(4):988-994.
[17]Freixinet JL,Varela G,Molins L,et al.Benchmarking in thoracic surgery[J].Eur J Cardiothorac Surg,2011,40(1):124-129.
[18]Kates M,Swanson S,Wisnivesky JP.Survival following lobectomy and limited resection for the treatment of stageⅠnon-small cell lung cancer≤1 cm in size:a review of SEER data[J].Chest,2011,139(3):491-496.
[19]Baldwin DR,Eaton T,Kolbe J,et al.Management of solitary pulmonary nodules:how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?[J].Thorax,2002,57(9):817-822.
[20]Revel MP,Merlin A,Peyrard S,et al.Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules[J].AJR Am J Roentgenol,2006,187(1):135-142.
[21]Slattery MM,Foley C,Kenny D,et al.Long-term followup of non-calcified pulmonary nodules(<10 mm)identified during low-dose CT screening for lung cancer[J].Eur Radiol,2012,22(9):1923-1928.
[22]Mc Nulty W,Cox G,Au-Yong I.Investigating the solitary pulmonary nodule[J].BMJ,2012,344:E2759.
[23]Kim HY,Shim YM,Lee KS,et al.Persistent pulmonary nodular ground-glass opacity at thin-section CT:histopathologic comparisons[J].Radiology,2007,245(1):267-275.
[24]Kodama K,Higashiyama M,Takami K,et al.Treatment strategy for patients with small peripheral lung lesion(s):intermediate-term results of prospective study[J].Eur J Cardiothorac Surg,2008,34(5):1068-1074.
[25]Mun M,Kohno T.Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter[J].J Thorac Cardiovasc Surg,2007,134(4):877-882.
[26]Carretta A,Ciriaco P,Melloni G,et al.Surgical treatment of multiple primary adenocarcinomas of the lung[J].Thorac Cardiovasc Surg,2009,57(1):30-34.
[27]Ikeda K,Awai K,Mori T,et al.Differential diagnosis of ground-glass opacity nodules:CT number analysis by three-dimensional computerized quantification[J].Chest,2007,132(3):984-990.
[28]Kim TJ,Goo JM,Lee KW,et al.Clinical,pathological and thin-section CT features of persistent multiple ground-glass opacity nodules:comparison with solitary ground-glass opacity nodule[J].Lung Cancer,2009,64(2):171-178.
[29]Ng YL,Patsios D,Roberts H,et al.CT-guided percutaneous fine-needle aspiration biopsy of pulmonary nodules measuring 10 mm or less[J].Clin Radiol,2008,63(3):272-277.